📣 VC round data is live. Check it out!
- Public Comps
- Welby
Welby Valuation Multiples
Discover Welby's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like ImExHS, MedApp, Physitrack, Metacare and more.
Welby Overview
About Welby
Welby Inc offers patients and their families digital tools helping medical treatment and prevention of the progression of disease. The company co-develops and co-provides digital services with pharmaceuticals, medical device companies, governments, along with patients and healthcare professionals.
Founded
2011
HQ

Employees
48
Website
Financials (LTM)
EV
$14M
Valuation Multiples
Start free trialWelby Financials
Welby reported last 12-month revenue of $4M.
In the same LTM period, Welby generated had net loss of ($4M).
Revenue (LTM)
Welby P&L
In the most recent fiscal year, Welby reported revenue of $4M and EBITDA of ($3M).
Welby is unprofitable as of last fiscal year, with gross margin of 68%, EBITDA margin of (76%), and net margin of (82%).
Financial data powered by Morningstar, Inc.
Welby Stock Performance
Welby has current market cap of $14M, and enterprise value of $14M.
Market Cap Evolution
Welby's stock price is $1.65.
Welby share price decreased by 3.9% in the last 30 days, and by 25.6% in the last year.
Welby has an EPS (earnings per share) of $-0.40.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $14M | $14M | -0.2% | -3.9% | -18.5% | -25.6% | $-0.40 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialWelby Valuation Multiples
Welby trades at 3.4x EV/Revenue multiple, and (4.5x) EV/EBITDA.
EV / Revenue (LTM)
Welby Financial Valuation Multiples
As of June 3, 2026, Welby has market cap of $14M and EV of $14M.
Welby has a P/E ratio of (4.0x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Welby Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Welby Margins & Growth Rates
In the most recent fiscal year, Welby reported gross margin of 68%, EBITDA margin of (76%), and net margin of (82%).
Welby Margins
Welby Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Welby Operational KPIs
Welby's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Welby Competitors
Welby competitors include ImExHS, MedApp, Physitrack, Metacare, CurveBeam AI, NRGene, Vidavo, iXensor, Media Lab and MRSO.
Most Welby public comparables operate across Digital Therapeutics, Healthcare Software, B2B SaaS, Vertical SaaS and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.6x | 0.5x | 10.0x | 8.3x | |||
| 14.0x | - | 56.5x | - | |||
| 0.9x | 1.1x | (7.2x) | 19.7x | |||
| 2.2x | - | 13.1x | - | |||
| 2.9x | 3.2x | (3.5x) | (3.5x) | |||
| 1.8x | - | (5.8x) | - | |||
| 3.9x | - | 10.3x | - | |||
| 10.8x | - | (7.3x) | - | |||
This data is available for Pro users. Sign up to see all Welby competitors and their valuation data. Start Free Trial | ||||||
Welby VC Funding History
Before going public, Welby raised $11M in total equity funding, across 4 rounds.
Welby Funding Rounds
Acquisitions by Welby
Welby has acquired 1 company to date.
Last acquisition by Welby was on April 9th 2024. Welby acquired Medaca for $1M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Welby
| Description | Medaca is a Tokyo-based developer of cloud, mobile, and web services for centralized health data management. Its platform aggregates patient records, lab results, and imaging from multiple providers, enabling secure sharing among Japanese hospitals and clinics. The system complies with national privacy laws for telemedicine and population health analytics. |
| HQ Country | |
| HQ City | Tokyo |
| Deal Date | 9 Apr 2024 |
| Valuation | $1M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Welby acquisitions and their M&A valuation multiples. Start Free Trial | |
Investments by Welby
Welby has invested in 1 company to date.
Latest investment by Welby was on August 9th 2023. Welby invested in Rehasaku in their $1M Seed round (EV/Revenue multiple available to Pro users).
Latest Investments by Welby
| Description | Rehasaku is a Tokyo-based platform supporting physiotherapists, judo therapists, and patients through digital tools for rehabilitation tracking and exercise guidance. The service provides video libraries of judo rehabilitation techniques, progress analytics, and remote consultations, used by clinics in Japan. Rehasaku integrates with wearable sensors for real-time data, aiding recovery from sports injuries and orthopedic conditions in partnership with judo federations. |
| HQ Country | |
| HQ City | Tokyo |
| Deal Date | 9 Aug 2023 |
| Round | Seed |
| Raised | $1M |
| Investors | ANRI; DNX Ventures; Welby |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Welby investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Welby
| When was Welby founded? | Welby was founded in 2011. |
| Where is Welby headquartered? | Welby is headquartered in Japan. |
| How many employees does Welby have? | As of today, Welby has over 48 employees. |
| Is Welby publicly listed? | Yes, Welby is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Welby? | Welby trades under 4438 ticker. |
| When did Welby go public? | Welby went public in 2019. |
| Who are competitors of Welby? | Welby main competitors include ImExHS, MedApp, Physitrack, Metacare, CurveBeam AI, NRGene, Vidavo, iXensor, Media Lab, MRSO. |
| What is the current market cap of Welby? | Welby's current market cap is $14M. |
| What is the current revenue of Welby? | Welby's last 12 months revenue is $4M. |
| What is the current EV/Revenue multiple of Welby? | Current revenue multiple of Welby is 3.4x. |
| Is Welby profitable? | No, Welby is not profitable. |
| What is the current net income of Welby? | Welby's last 12 months net income is ($4M). |
| How many companies Welby has acquired to date? | As of June 2026, Welby has acquired 1 company. |
| What was the largest acquisition by Welby? | $1M acquisition of Medaca on 9th April 2024 was the largest M&A Welby has done to date. |
| What companies Welby acquired? | Welby acquired Medaca. |
| In how many companies Welby has invested to date? | As of June 2026, Welby has invested in 1 company. |
| What was the last Welby investment? | On 9th August 2023 Welby invested in Rehasaku, participating in a $1M Seed round, alongside ANRI and DNX Ventures. |
| In what companies Welby invested in? | Welby invested in Rehasaku. |
See public comps similar to Welby
Lists including Welby
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
